Picard Medical, Inc. (PMI) - Net Assets
Based on the latest financial reports, Picard Medical, Inc. (PMI) has net assets worth $3.79 Million USD as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($22.55 Million) and total liabilities ($18.76 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check financial resilience of Picard Medical, Inc. to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $3.79 Million |
| % of Total Assets | 16.8% |
| Annual Growth Rate | -30.66% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Picard Medical, Inc. - Net Assets Trend (2022–2025)
This chart illustrates how Picard Medical, Inc.'s net assets have evolved over time, based on quarterly financial data. Also explore Picard Medical, Inc. assets under control for the complete picture of this company's asset base.
Annual Net Assets for Picard Medical, Inc. (2022–2025)
The table below shows the annual net assets of Picard Medical, Inc. from 2022 to 2025. For live valuation and market cap data, see how much is Picard Medical, Inc. worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $3.79 Million | +115.96% |
| 2024-12-31 | $-23.74 Million | -568.24% |
| 2023-12-31 | $-3.55 Million | -131.24% |
| 2022-12-31 | $11.37 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Picard Medical, Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 6362600000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $7.00K | 0.18% |
| Other Comprehensive Income | $228.00K | 6.02% |
| Other Components | $80.40 Million | 2121.85% |
| Total Equity | $3.79 Million | 100.00% |
Picard Medical, Inc. Competitors by Market Cap
The table below lists competitors of Picard Medical, Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Pivotal Metals Ltd
AU:PVT
|
$12.99 Million |
|
FASING SA
WAR:FSG
|
$13.00 Million |
|
Mico BioMed Co. Ltd.
KQ:214610
|
$13.00 Million |
|
Jocil Limited
NSE:JOCIL
|
$13.00 Million |
|
PZ Cormay SA
WAR:CRM
|
$12.98 Million |
|
Mixed Martial Arts Group Limited
NYSE MKT:MMA
|
$12.98 Million |
|
Thai Packaging & Printing Public Company Limited
BK:TPP
|
$12.97 Million |
|
Serica Energy PLC
LSE:SQZ
|
$12.97 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Picard Medical, Inc.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from -23,736,000 to 3,789,000, a change of 27,525,000.
- Net loss of 27,000,000 reduced equity.
- New share issuances of 17,444,000 increased equity.
- Other comprehensive income decreased equity by 50,000.
- Other factors increased equity by 37,131,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-27.00 Million | -712.59% |
| Share Issuances | $17.44 Million | +460.39% |
| Other Comprehensive Income | $-50.00K | -1.32% |
| Other Changes | $37.13 Million | +979.97% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Picard Medical, Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.74x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 0.89x to 2.74x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2022-12-31 | $0.16 | $0.14 | x |
| 2023-12-31 | $-0.05 | $0.14 | x |
| 2024-12-31 | $-0.33 | $0.14 | x |
| 2025-12-31 | $0.05 | $0.14 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Picard Medical, Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -712.59%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -546.56%
- • Asset Turnover: 0.22x
- • Equity Multiplier: 5.95x
- Recent ROE (-712.59%) is below the historical average (-202.71%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2022 | -98.23% | -271.53% | 0.27x | 1.36x | $-12.30 Million |
| 2023 | 0.00% | -308.72% | 0.44x | 0.00x | $-15.21 Million |
| 2024 | 0.00% | -479.50% | 0.36x | 0.00x | $-18.68 Million |
| 2025 | -712.59% | -546.56% | 0.22x | 5.95x | $-27.38 Million |
Industry Comparison
This section compares Picard Medical, Inc.'s net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $757,800,566
- Average return on equity (ROE) among peers: -54.77%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Picard Medical, Inc. (PMI) | $3.79 Million | -98.23% | 4.95x | $12.98 Million |
| Abbott Laboratories (ABT) | $7.43 Billion | 32.93% | 0.95x | $152.62 Billion |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $19.91 Million | -270.00% | 1.43x | $18.77 Million |
| Aethlon Medical Inc (AEMD) | $-7.09 Million | 0.00% | 0.00x | $2.76 Million |
| Acutus Medical Inc (AFIB) | $75.02 Million | -52.81% | 0.78x | $903.35K |
| Adapthealth Corp (AHCO) | $15.14 Million | -140.98% | 14.05x | $1.39 Billion |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $6.89 Million | 30.07% | 0.49x | $12.47 Million |
| Allurion Technologies, Inc. (ALUR) | $19.83K | -26.07% | 15.64x | $9.70 Million |
| Autonomix Medical, Inc. Common Stock (AMIX) | $8.10 Million | -140.88% | 0.21x | $3.99 Million |
| Artivion Inc (AORT) | $30.20 Million | 15.56% | 0.78x | $1.11 Billion |
| Apyx Medical Inc (APYX) | $2.22 Million | 4.46% | 0.72x | $153.68 Million |
About Picard Medical, Inc.
Picard Medical, Inc., together with its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure. The company operates in the United States, Europe, and internatio… Read more